Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 13Recruiting 5Unknown 4Withdrawn 2Terminated 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lung Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Breast Neoplasms 4Glioblastoma 3Colorectal Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia 2Glioma 2Endometrial Neoplasms 2Carcinoma, Squamous Cell 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Uterine Cervical Neoplasms 1Urologic Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Solid Tumor 1Small Cell Lung Carcinoma 1Sezary Syndrome 1Sarcoma 1Rhabdoid Tumor 1Renal Insufficiency 1Recurrence 1Prostatic Neoplasms 1Precancerous Conditions 1Postoperative Complications 1Pancreatic carcinoma, familial 1

Interventions

osimertinib 1Spinal Puncture 1Leukapheresis 1Hematologic Tests 1Blood Specimen Collection 1Bevacizumab 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Neoplastic Cells, Circulating × Blood Specimen Collection × Clear all
NCT07398170 2026-02-09

BIOLIMEN-1

University Hospital, Montpellier

Phase NA Not yet recruiting
15 enrolled
CNS

Meningioma, Neoplastic Cells, Circulating, Neoplasm Recurrence, Local

Data powered by HemOnc (CC BY 4.0) Colophon âš¡